Publications by authors named "R Zh Bruvere"

HCV core is an attractive HCV vaccine target, however, clinical or preclinical trials of core-based vaccines showed little success. We aimed to delineate what restricts its immunogenicity and improve immunogenic performance in mice. We designed plasmids encoding full-length HCV 1b core and its variants truncated after amino acids (aa) 60, 98, 152, 173, or up to aa 36 using virus-derived or synthetic polynucleotides (core191/60/98/152/173/36_191v or core152s DNA, respectively).

View Article and Find Full Text PDF

HBV core protein (HBc), the major component of nucleocapsid is known to have an essential role in the virus life cycle as the transporter of virus genome to the host nucleus; however, molecular details of the intracellular transport of HBc remain unknown. In this study, we investigated the intracellular distribution of the HBc protein resulting from Semliki Forest virus (SFV)-driven HBc gene and HBV RNA pregenome (pgRNA) expression in BHK-21 cells. Fluorescent confocal microscopy revealed extensive HBc protein synthesis in the cytoplasm 12 hr post infection (p.

View Article and Find Full Text PDF

Double-stranded RNA (dsRNA) is a pathogen-associated molecular pattern, known for its ability to induce antiviral response and enhance communication between cells mediating innate and adaptive immune responses. The aim of this study was to characterize the effect of the dsRNA-containing product Larifan on the production of a wide spectrum of cytokines and chemokines in ex vivo cultivated peripheral blood mononuclear cells. Concentrations of 29 different cytokines were detected by a Luminex® 200™ System using three Milliplex MAP Multiplex Assay Kits.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated how modifications to the hepatitis B virus (HBV) subviral particle, specifically a deletion variant known as 1-48preS/S, affect its secretion and immunogenic properties.
  • The removal of the N-terminal myristoylation signal in a modified version led to a slight reduction in the secretion efficiency, but it didn't change the glycosylation patterns significantly.
  • Findings suggest that while myristoylation enhances the compact and effective localization of the precursor proteins, the structure and surface epitopes of 1-48preS/S could contribute positively to developing future hepatitis B vaccines.
View Article and Find Full Text PDF
Article Synopsis
  • Most hepatitis B vaccines typically use the viral small surface protein subtype adw2 produced in yeast, but challenges such as variant resistance and immune response issues exist.
  • Researchers developed recombinant Semliki Forest virus (rSFV) vectors to express different surface proteins, including S and a segment of the large surface protein called pre-S1, targeting areas known for antibody binding.
  • Mice immunized with these rSFV vectors produced neutralizing antibodies effective against various hepatitis B virus strains, with the pre-S1.1-48/S vector showing a strong Th1 immune response and potential for broad protection against S-escape variants.
View Article and Find Full Text PDF